NEWS

Medical freedom threatened: New bill could grant Big Pharma the power to ban off-label drugs

Updated: February 14, 2023 at 12:57 pm EST  See Comments

Tue Feb 14, 2023 – 12:43 pm EST

Note from LifeSite president Steve Jalsevac: This article presents an excellent overview of a new health development requiring action from U.S. readers. Federal elected officials should be contacted to educate them about the serious implications of this new legislation as explained in the article and to demand that they work to have it retracted.

STORY AT-A-GLANCE The 2023 omnibus appropriations bill includes 19 lines that could give the U.S. Food and Drug Administration the power to ban off-label use of approved medications. If the little-noticed provision is passed, doctors’ ability to freely treat patients, and patients’ ability to use all available treatments after making an informed decision, will be lost. The amendment puts the FDA, and by proxy Big Pharma, at the helm of powerful health care decisions that should be made on an individual, personalized level between a patient and their health care provider. In California, law AB 2098, which went into effect January 1, 2023, gives the state power to take away doctors’ medical licenses if they spread “misinformation” that goes against the standard COVID-19 rhetoric. The trend to allow a Pharma-controlled government to silence

The remainder of this article is available in its entirety at LifeSite News

The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors

Advertisement
Ledger Nano S Cryptocurrency Wallet
0 0 votes
Article Rating
Subscribe
Notify of
guest

0 Comments
Inline Feedbacks
View all comments
A Quick Note…

Already a subscriber? Login to remove advertisements. Not a subscriber? Join the Official Street Preachers and gain access to hundreds of presentations and exclusives that cover today's events and how they impact you, your life, and your soul. All while supporting independent Christian researchers trying to make a difference.